Biopharma Executive Advocates Bitcoin as a Solution for Surviving the Biotech Winter Challenges
Atai Life Sciences, a biopharmaceutical company listed on NASDAQ, believes that cryptocurrencies like Bitcoin could be crucial for the survival of biotech startups facing lengthy regulatory processes. The company, which develops mental health treatments using psychedelics, announced plans to purchase $5 million in Bitcoin. Founder Christian Angermayer noted that drug development is an expensive, long-term ...
